Intas Biopharmaceuticals Limited (IBPL) has fully integrated biopharmaceutical operations at Ahmedabad, Gujarat. Since the launch of biotechnology operations in May 2000, Research & Development (R&D) and manufacturing of biopharmaceutical products with a special focus on Oncology (Cancer) are major thrust areas for the company. Being India’s first and only biopharmaceuticals company to receive EUROPEAN UNION – GOOD MANUFACTURING PRACTICE (EU-GMP) certification for its manufacturing facility, IBPL has carved a niche in the biopharmaceutical operations. Recently the company has received quality certification from MEDICINES CONTROL COUNCIL (MCC) – SOUTH AFRICA and GULF COOPERATION COUNCIL (GCC). In terms of quality standards, the facility complies with strict international Good Manufacturing Practice regulations and conforms to guidelines laid down by WORLD HEALTH ORGANIZATION (WHO).